Bacterial Skin Infections cream in pharma franchise in Jharkhand

Bacterial Skin Infections cream PCD pharma franchise in Bhubaneswar

Bacterial Skin Infections cream in top pharma company in Indore

Bacterial Skin Infections cream in pcd pharma supplier in Imphal

Bacterial Skin Infections cream in phama franchise company in India
Bacterial Skin Infections cream in phama distributor in Jaipur

Home/Products /ofloxacin-0-point-75-ornidazole-preservatives-cream-cream

Diziderm IT Cream

Composition : Ofloxacin 0.75% + Ornidazole 2% + Itraconazole 1% + Clobetasole 0.05% + Preservatives Cream

Dosage Form : Cream

Packaging Type : Tube

Packaging : 15gm

Price : ₹92/-

Diziderm IT Cream is a multi-action topical formulation designed to address a variety of skin infections caused by bacteria, fungi, and inflammation. It combines four active ingredients:

  • Ofloxacin (0.75%): A broad-spectrum antibiotic that inhibits bacterial DNA replication, effectively controlling bacterial infections.
  • Ornidazole (2%): An antiprotozoal and antibacterial agent that treats anaerobic infections and prevents microbial growth.
  • Itraconazole (1%): A potent antifungal that combats fungal infections, particularly those caused by dermatophytes and yeasts.
  • Clobetasol (0.05%): A corticosteroid that reduces inflammation, redness, and itching associated with skin conditions.

This synergistic combination provides comprehensive relief from mixed infections involving bacteria, fungi, and inflammation. It is especially effective for conditions like fungal dermatitis, tinea infections, seborrheic dermatitis, and bacterial superinfections. The addition of preservatives ensures the cream’s stability and effectiveness over time.

The lightweight and easy-to-apply formulation penetrates deeply into the skin, offering rapid relief from symptoms such as itching, redness, scaling, and discomfort. Its multi-pronged approach makes it an essential treatment for dermatological conditions requiring antibacterial, antifungal, and anti-inflammatory actions.

Read More

About the Product

Diziderm IT Cream is a multi-action topical formulation designed to address a variety of skin infections caused by bacteria, fungi, and inflammation. It combines four active ingredients:

  • Ofloxacin (0.75%): A broad-spectrum antibiotic that inhibits bacterial DNA replication, effectively controlling bacterial infections.
  • Ornidazole (2%): An antiprotozoal and antibacterial agent that treats anaerobic infections and prevents microbial growth.
  • Itraconazole (1%): A potent antifungal that combats fungal infections, particularly those caused by dermatophytes and yeasts.
  • Clobetasol (0.05%): A corticosteroid that reduces inflammation, redness, and itching associated with skin conditions.

This synergistic combination provides comprehensive relief from mixed infections involving bacteria, fungi, and inflammation. It is especially effective for conditions like fungal dermatitis, tinea infections, seborrheic dermatitis, and bacterial superinfections. The addition of preservatives ensures the cream’s stability and effectiveness over time.

The lightweight and easy-to-apply formulation penetrates deeply into the skin, offering rapid relief from symptoms such as itching, redness, scaling, and discomfort. Its multi-pronged approach makes it an essential treatment for dermatological conditions requiring antibacterial, antifungal, and anti-inflammatory actions.

Mild irritation, burning sensation, or redness at the application site may occur. Prolonged use can cause skin thinning or discoloration.

Diziderm IT Cream is indicated for mixed bacterial and fungal skin infections, including tinea infections, fungal dermatitis, and inflammatory skin conditions with secondary infections.

For external use only. Avoid contact with eyes and mucous membranes. Use under medical supervision.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation